GENEVA, July 2 -- THE GENERAL HOSPITAL CORPORATION filed a patent application (US2025/059654) for “USING RITUXIMAB TO PREVENT CAR-T OR TEAM IMMUNITY”. With publication no. WO/2026/136239, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....